Royalty Report: Medical, cardiac, Catheter – Collection: 230829


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • cardiac
  • Catheter
  • Device
  • Diagnostic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 230829

License Grant
Licensee previously acquired from in a License Agreement effective as of January 15, 1995, the Prior Agreement, an option to acquire the exclusive worldwide right and license, with a right to sublicense, in and to the MAC Technology and Licensor Patent Rights to make, have made, use and sell products covered thereby and to practice processes and methods, the Option.

Licensee exercised the Option in accordance with the terms of the Prior Agreement, and the parties desire to set forth the terms and conditions of the license granted pursuant to the Option in this Agreement.

Effective as of February 14, 1996 the Option Exercise Date, and subject to the terms and conditions set forth, Licensor hereby grants to Licensee an exclusive, non-transferable, worldwide right and license, with the right to sublicense the same as provided herein, in and to the MAC Technology to make, have made, use and sell, or otherwise dispose of products, and practice processes and methods thereunder.

License Property
Licensor has developed or acquired and is the-owner of all right, title and interest in certain patent rights and the inventions covered thereby, as well as KnowHow, relating to methods and apparatus comprising and related to a certain device known as the mechanical angioplasty catheter, MAC, that combines blood perfusion and coronary balloon angioplasty in a single device to treat vascular stenoses.
Field of Use
Licensee is and has been engaged in the discovery, development, manufacture and sale of medical devices for the diagnosis and treatment of vascular disease, including angioplasty balloon catheters having blood perfusion capability, and continues to be active in this area.

IPSCIO Record ID: 310350

License Grant
Licensor grants a worldwide, non-transferable, and non-sub licensable license to make, have made, use and sell Licensed Products in the Field of Use.  The licensed granted shall be co-exclusive, meaning that Licensor or any Affiliate of Licensor shall also have the worldwide right to make, have made, use, sell or otherwise commercialize and exploit the Licensed Technology in the Field of Use, provided that Licensor shall not grant any licenses to the Licensed Technology in the Field of Use during the term of this Agreement.
License Property
Licensor has developed certain technology related to catheter navigation and mapping.

Licensor is a medical device company, with products including cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, and patient monitoring systems.

This agreement is for the technology, patent and applications are for Catheter Mapping System and Application, including, specifically, U.S Patent No 5,697,377, and all trade secrets and know-how owned by Licensor prior to the date of this Agreement which relate specifically and directly to 3-D electrode localization devices and techniques as disclosed in the patents or patent applications, including but not necessarily limited to software developed specifically to practice the inventions disclosed in the patents included in the Licensed Technology, and new patents arising out of patent applications filed, or inventions reduced to practice and relate specifically and directly to 3-D electrode localization devices and techniques.

Field of Use
The Field of Use shall mean electrophysiological intracardiac mapping applications for the treatment of cardiac arrhythmias.

Licensee is engaged in the development of the EnSite diagnostic catheter and clinical workstation for use by electrophysiologists in diagnosing and mapping abnormal heart rhythms known as tachycardias.

IPSCIO Record ID: 308743

License Grant
Licensor grants to Licensee a worldwide, exclusive license to make, have made, use and sell Royalty Products.
License Property
Royalty Product means any Lead Extractor covered by a claim of an unexpired patent in the Licensed Intellectual Property or employing Licensor Confidential Information in the Licensed Intellectual Property; provided that the laser generators and other capital equipment of Licensee will not be considered Royalty Product. Lead Extractors sold for the purpose of clinical trials required for obtaining government approval to market in any country shall not be deemed Royalty Product.

Lead Extractor means a device for aiding in removal of medical devices such as pacing and defibrillation leads or catheters.

Licensed Intellectual Property means (1) All U.S. patents and patent applications owned by or licensed to, with the right to sublicense, Licensor which are now or during the term of this Agreement developed for use in the laser extraction of leads or catheters, including U.S. Patent 5,423,806 entitled 'Laser Extractor for an Implanted Object' and U.S. Patent Application 08/153,715 entitled 'Heart Synchronized Extractor for an Implanted Object'; (2) all patent rights derived from such patents and patent applications, including but not limited to foreign rights, divisionals, continuations, continuations in part, re-issues, and reexaminations; and (3) any confidential information provided to Licensee by Licensor (a) under the terms of the Agreement for Mutual Exchange of Confidential Information between Licensee and Licensor dated May 21, 1991 (the Confidentiality Agreement), (b) in written form and marked as proprietary, confidential or the like, before and during the development of Licensee products, including but not limited to the original concept drawings and information disclosures (collectively the Licensor Confidential Information).  Licensor Confidential Information shall not, however, include information which
    (i)   is or was known to Licensee prior to receipt thereof under this Agreement or the Confidentiality Agreement, as evidenced by written records;
    (ii)  is disclosed without restriction to Licensee in good faith by a third party who is in lawful possession thereof and who has the right to make such disclosure;
    (iii) is or shall have become public knowledge, by publication or otherwise, through no fault of Licensee;  
    (iv)  is discovered by Licensee completely without reference to Licensor Confidential Information; or
    (v)   is transmitted to Licensee by Licensor after Licensor received notification in writing from Licensee that Licensee did not desire to receive any further Licensor Confidential information.

U.S. Patent 5,423,806 entitled Laser Extractor for an Implanted Object
U.S. Patent Application 08/153,715 entitled Heart Synchronized Extractor for an Implanted Object

Licensor has developed technology relating to laser lead extraction and owns intellectual property related thereto.

Field of Use
The field of use is in the medical industry relating to devices for aiding in removal of medical devices such as pacing and defibrillation leads or catheters.

Licensee develops, manufactures, markets, and distributes its technology for interventional cardiovascular therapy. The Companys system is used in applications such as coronary angioplasty and the removal of pacemaker leads.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.